BCA
QTTB icon

Berman Capital Advisors’s Q32 Bio QTTB Stock Holding History

Berman Capital Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$0 Buy
+6
New +$764 ﹤0.01% 2255

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berman Capital Advisors's QTTB Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Q32 Bio (QTTB) in Q3 2021: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2255 among its holdings.

119 funds tracked by Wall St. Rank hold QTTB as of Q3 2021.

  • Berman Capital Advisors held 6 shares of Q32 Bio worth $0 as of Q3 2021.
  • Q32 Bio was a new Berman Capital Advisors position in Q3 2021.
  • Q32 Bio made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2255 holding.
  • 119 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.